Staphylococcus aureus infections in kidney transplantation: A matched case controlled study

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 6, 2012, Pages 427-432

  Florescu, Diana F ^a   Qiu, Fang ^b   West, Sara Brostrom ^c   Richards, Sarah ^c   Florescu, Marius C ^d   Stevens, Brian ^e   Hill, Lisa ^a   Kalil, Andre C ^a  

^a Transplant Infectious Diseases Program   (United States)

^b Biostatistics Department   (United States)

^c Internal Medicine Department   (United States)

^d Nephrology Section   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Kidney; Outcome; Risk factors; Staphylococcus aureus; Transplant

Indexed keywords

CEFADROXIL; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; STEROID; VANCOMYCIN;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; KIDNEY TRANSPLANTATION; LUNG INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; SURGICAL MORTALITY; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STEROIDS; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84861602842     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.652160     Document Type: Article

References (17)

1. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005;165:1756-61.
2. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5:9-17.
3. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9.
5. Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl 2005;11:1093-9.
6. Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993;80:27-38.
7. Heinze G, Puhr R. Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets. Stat Med 2010;29:770-7.
8. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 2007;59:401-6.
9. Munoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin Infect Dis 2001;33(Suppl 1):S53 - 7.
10. Bert F, Galdbart JO, Zarrouk V, Le Mee J, Durand F, Mentre F, et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 2000;31:1295-9.
11. Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003;9:754-9.
12. Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Moriya K, et al. Methicillin-resistant Staphylococcus aureus infection after living-donor liver transplantation in adults. Transpl Infect Dis 2008;10:110-6.
13. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-286.
14. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009;(1):CD 005632.
15. Singh N. Infections in solid organ transplant recipients. Curr Opin Infect Dis 2000;13:343-7.
16. Torre-Cisneros J, Herrero C, Canas E, Reguera JM, De La Mata M, Gomez-Bravo MA. High mortality related with Staphylococcus aureus bacteremia after liver transplantation. Eur J Clin Microbiol Infect Dis 2002;21:385-8.
17. Schneider CR, Buell JF, Gearhart M, Thomas M, Hanaway MJ, Rudich SM, et al. Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc 2005;37:1243-4.